Ibrance and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ibrance (palbociclib) and Tacrolimus (tacrolimus). Common drug interactions include inner ear disorder among females.

The phase IV clinical study analyzes what interactions people have when they take Ibrance and Tacrolimus. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

On Jul, 07, 2026

18 people who take Ibrance and Tacrolimus together, and have interactions are studied.

Ibrance and Tacrolimus drug interactions.

What are the common drug interactions of Ibrance and Tacrolimus, by gender? *:

female:

Inner ear disorder
Vertigo
Red blood cell count decreased
White blood cell count decreased
Alopecia (absence of hair from areas of the body)
Death
Decreased appetite
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Ejection fraction decreased (systolic heart failure)

male:

n/a

What are the common drug interactions of Ibrance and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Inner ear disorder
Vertigo
Asthenia (weakness)
Decreased immune responsiveness
Pain in jaw
Tooth disorder (tooth disease)
Tooth fracture
Toothache (tooth pain)
Immune system disorder
Alopecia (absence of hair from areas of the body)

50-59:

Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Coronary arterial stent insertion
Cystitis (inflammation of the wall of the bladder)
Diarrhoea
Fatigue (feeling of tiredness)
Gastric neoplasm (a tumour that develops in the stomach)
Urinary tract infection

60+:

Fatigue (feeling of tiredness)
Platelet count decreased
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Oral pain
Pruritus (severe itching of the skin)
Anion gap decreased
Blood creatinine increased
Blood urea increased
Carbohydrate antigen 27.29 increased
Diarrhoea

What are the existing conditions these people have? *

Breast Cancer Female: 6 people, 33.33%
Breast Cancer Metastatic: 3 people, 16.67%
Breast Cancer: 3 people, 16.67%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 5.56%
Positron Emission Tomogram Abnormal: 1 person, 5.56%
Nausea (feeling of having an urge to vomit): 1 person, 5.56%
Metastases To Lung (cancer spreads to lung): 1 person, 5.56%
Herpes Zoster: 1 person, 5.56%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 5.56%
Cough: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ibrance and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously